DH-I-180-3-mediated photodynamic therapy: biodistribution and tumor vascular damage

Photochemistry and Photobiology
Dae-Seog LimWon-Young Lee

Abstract

An important goal of photodynamic therapy (PDT) for treatment of various cancers is to shorten PDT-performing time and simultaneously enhance PDT efficacy. Here, we investigated the nontumor tissue distribution of and the tumor vascular damage caused by a new photosensitizer, DH-I-180-3, in mice with implanted EMT6 mammary tumor cells. In addition, we performed cell-based assays to evaluate the basic antitumor effect of DH-I-180-3/PDT in EMT6 cells. After administration of PDT, the type of cell death was characterized to be apoptosis, and a change in the mitochondrial membrane potential was also observed within minutes. On the other hand, tumor growth was remarkably retarded in vivo in mice that received DH-I-180-3/PDT, compared with mice in the control group, which were exposed to light irradiation alone. Finally, tumors in some mice nearly healed. The antitumor drug reached a maximum concentration approximately 3 h after administration. However, PDT was most effective when there was substantial accumulation of DH-I-180-3 in the tumor vasculature and in healthy tissue. The histological demonstration provided further evidence of tumor vascular damage. On the basis of these findings, we suggest that PDT with the photosensitizer ...Continue Reading

References

Jan 1, 1992·Photochemistry and Photobiology·B W Henderson, T J Dougherty
May 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·S T SmileyL B Chen
Jun 1, 1990·Journal of Photochemistry and Photobiology. B, Biology·C J ByrneA D Ward
Sep 1, 1989·The Journal of Urology·M W ReedF N Miller
Jan 1, 1988·International Journal of Radiation Oncology, Biology, Physics·T UmsawasdiD T Carr
Dec 1, 1994·Annals of Medicine·D I Rosenthal, E Glatstein
Apr 1, 1995·Photochemistry and Photobiology·F A Menezes da Silva, E L Newman
Dec 15, 1994·International Journal of Cancer. Journal International Du Cancer·K Berg, J Moan
Aug 1, 1993·Photochemistry and Photobiology·D KesselB Henderson
Oct 23, 1997·International Journal of Cancer. Journal International Du Cancer·R VeenhuizenF Stewart
Feb 21, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W S ChanJ E van Lier
Apr 16, 1998·Journal of Photochemistry and Photobiology. B, Biology·D Kessel, Y Luo
Oct 1, 1996·Journal of Clinical Laser Medicine & Surgery·V H Fingar
Jun 24, 1998·Journal of the National Cancer Institute·T J DoughertyQ Peng
Jan 30, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·F StewartW Star
Apr 14, 1999·Cell Death and Differentiation·D Kessel, Y Luo
May 18, 1999·Lasers in Surgery and Medicine·M J Hammer-WilsonM W Berns
Oct 26, 1999·Drug Discovery Today·W M Sharman van Lier JE
Aug 9, 2002·Journal of Photochemistry and Photobiology. B, Biology·Dae-Seog LimWon-Young Lee
Mar 27, 2004·Journal of Photochemistry and Photobiology. B, Biology·Dae-Seog LimWon-Young Lee

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis
fluorescence microscopy

Software Mentioned

GraphPad Prism

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.